These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16265179)

  • 1. How effective are quadruple therapies as first-line H. pylori eradication therapies?
    Borody TJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):174-5. PubMed ID: 16265179
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
    Fischbach LA; van Zanten S; Dickason J
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.
    Gisbert JP
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):307-9. PubMed ID: 21643037
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
    Rokkas T; Sechopoulos P; Robotis J; Pistiolas D
    Am J Gastroenterol; 2006 Aug; 101(8):1938; author reply 1938-9. PubMed ID: 16928256
    [No Abstract]   [Full Text] [Related]  

  • 8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
    Baker DE
    Rev Gastroenterol Disord; 2008; 8(1):33-41. PubMed ID: 18477968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori: what schemes of eradication are essential today?].
    Maev IV; Samsonov AA; Golubev NN
    Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH).
    Oderda G; Shcherbakov P; Bontems P; Urruzuno P; Romano C; Gottrand F; Gómez MJ; Ravelli A; Gandullia P; Roma E; Cadranel S; De Giacomo C; Canani RB; Rutigliano V; Pehlivanoglu E; Kalach N; Roggero P; Celinska-Cedro D; Drumm B; Casswall T; Ashorn M; Arvanitakis SN;
    Helicobacter; 2007 Apr; 12(2):150-6. PubMed ID: 17309752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication and reinfection.
    Treiber G; Klotz O
    Lancet; 1995 Jun; 345(8965):1647; author reply 1647-8. PubMed ID: 7783566
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.